PTC Therapeutics, Inc. (PTCT)

70.66 +0.76 (+1.09%) USD  |  NASDAQ  |  Feb 20, 16:00
70.59 -0.07 (-0.10%) After-Hours: 20:00
More

PTC Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for PTCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Ardelyx, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade